dentalcorp — Q2 2025 Earnings Presentation
27 slides from dentalcorp's earnings presentation, Aug 8, 2025
Slide 1: Investor Presentation Q2 2025
Investor Presentation Q2 2025 TSX: DNTL
Slide 2: Disclaimer
Disclaimer Any graphs, tables or other information demonstrating our historical performance or that of any other entity contained in this presentation are intended only to illustrate past performance and are not necessarily indicative of such entities' future performance. Investors should not assume
Slide 3: Company Overview
Company Overview Investment Highlights Appendix
Slide 4: Dentalcorp by the Numbers
Dentalcorp by the Numbers Our people1 LTM performance2 1,850+ Dentists ▪ PF Revenue3 of $1.7 billion and PF Adjusted EBITDA3 of $314 million 2,800+ Dental Hygienists, and 5,950+ Auxiliary Dental Health Professionals ▪ Acquired 36 new Practices, expected to generate $28 million in PF Adjusted EBITDA3
Slide 5: Canada's Largest National Network of Dental Practices
Canada’s Largest National Network of Dental Practices LTM Q2 2025 Revenue Breakdown Over 90% of Revenue in Routine Care 575 Practices Low exposure to more-cyclical procedures Located within 20km of ~80% of the Canadian population Practices as at Period End 5
Slide 6: Beyond Brilliant through Frictionless Dentistry
Beyond Brilliant through Frictionless Dentistry We Make Dentistry Easier for Patients and Professionals by Combining Scale, Expertise, and Technology AI, digital workflows, and Access to top clinicians, ongoing Industry-leading standards and clinical protocols automation to enhance efficiency educat
Slide 7: Delivering Exceptional Care to Our Communities
Delivering Exceptional Care to Our Communities EXPANDING ACCESS TO CARE ADVANCING THE PROFESSION OUR VALUES ▪ Commitment to pediatric dentistry, including ▪ Developing the next generation of clinicians more than $500k f fC ’ through mentorship, scholarships, and ’ continuing education. ▪ Over $3.8 m
Slide 8: Attracting, Developing & Retaining Top Industry Talent
Attracting, Developing & Retaining Top Industry Talent How We Win Talent Winning Recruitment Values-Based Culture Training and Development Optimized Talent Management ▪ Award-winning Recruitment team ▪ Purpose & values embedded ▪ Award-winning continuous education program ▪ Flexible locations & abil
Slide 9: An Essential and Highly Recurring Healthcare Service, Insulated from Economic Cycles
An Essential and Highly Recurring Healthcare Service, Insulated from Economic Cycles and Disintermediation by Technology 5 9 CANADIAN DENTAL Recessionary Period SERVICES EXPENDITURE 0 PER CAPITA1 5 8 9 80 81 82 8 84 85 8 8 88 89 90 91 92 9 94 95 9 9 98 99 00 01 02 0 04 05 0 0 08 09 10 11 12 1 14 15
Slide 10: A Differentiated Private, Cash-Pay Model
A Differentiated Private, Cash-Pay Model Primarily direct cash pay Most patients pay directly at the time of service Neutral to negative working capital PATIENTS May submit claim on Limited exposure to insurance behalf of companies or government pay Reimbursement patient Technology infrastructure fu
Slide 11: Balanced Approach to Driving Sustained Growth
Balanced Approach to Driving Sustained Growth ▪ Same Practice Revenue Growth1,2 supported by: 1 ▪ Expansion of specialty service offerings (e.g., clear aligner orthodontic treatment, implants) ORGANIC 4%+ Medium-term target for Same Practice Revenue Growth1,2 ▪ Our leading technology stack, includin
Slide 12: Revenue Growth Engine Powered by the Dentalcorp Advantage
Revenue Growth Engine Powered by the Dentalcorp Advantage Dentalcorp is one of the few providers with the scale to implement programs that support: Attracting New Expansion of Service Increased Patients Offerings and Capabilities Frequency of Visits ▪ Sophisticated marketing playbooks including ▪ Co
Slide 13: Playbooks to Drive Practice-Level EBITDA Margin Expansion
Playbooks to Drive Practice-Level EBITDA Margin1 Expansion Labour Procurement Exclusive Technology Platforms ▪ Predictive labour management ▪ National vendor consolidation across major ▪ Continuous enhancements of internal tools spend categories (dc market, dc assist, dc safety) ▪ Labour sharing acr
Slide 14: Leveraging Technology to Drive Continued Scalability and Growth
Leveraging Technology to Drive Continued Scalability and Growth Leading Technology Stack Best-in-Class Clinical Actionable Data Artificial Intelligence and Insights ▪ Leading tools standard across our practices for: ▪ Partnership with VideaHealth to use their AI for ▪ Daily consolidation of data fro
Slide 15: Large Opportunity for Continued Growth through Consolidation
Large Opportunity for Continued Growth through Consolidation, Further Driving Efficiency and Scale ractices in P Ca Total practices in Canada1: 00 DSOs # of Locations and ~16,000 ~10,000 na Market Share1 0 Practices that meet 6, da selection criteria for ~1 575 Identified opportunities: Partner acqu
Slide 16: Scalable, Repeatable Practice Integration Platform
Scalable, Repeatable Practice Integration Platform 10-15% expected increase in visit frequency2 Marketing Labour management LOI signed Virtual systems Closing assessment and protocols Day 0 training Day 45-90 plan development 12 Months LOI / Diligence Phase Integration Phase2 Virtual, Automated Prac
Slide 17: Compelling Financial Profile with Robust and Expanding Margins
Compelling Financial Profile with Robust and Expanding Margins, Low Capex Requirements, and Capped Interest Rate Exposure $2.9M 22%+ 4%+ Average Revenue Average Practice-Level Medium-Term Target Same per Practice EBITDA after Rent Margin1 Practice Revenue Growth1,2,3 PREDICTABLE CONVERSION4 ($M) Mea
Slide 18: Highly Recurring and Sustainable Revenue Growth
Highly Recurring and Sustainable Revenue Growth Recurring Patient Visits1 Mean: 88.9% 2022 2023 2024 2025 Same Practice Revenue Growth2 Mean: 3.9% 2022 2023 2024 2025 Active Patients1 2022 2023 2024 2025 Highly Recurring Revenue at Scale Driving Predictable and Durable Growth 18 1 Figures based on t
Slide 19: Proven Ability to Deleverage
Proven Ability to Deleverage Capital allocation program and balance sheet management has led to steady deleveraging toward our Medium-Term target range Net Debt / PF Adjusted EBITDA after rent Ratio (x)1 3.5x Medium-Term Target 3.0x 19 1 Non-IFRS financial measure, non-IFRS ratio or supplementary fi
Slide 20: Investment Highlights
Company Overview Investment Highlights Appendix
Slide 21: Investment Highlights
Investment Highlights 1 Large Addressable Market 2 Highly Recurring, Cash Pay, Essential Healthcare Canadian dental market: $22B in size and only ~7% consolidated 92% recurring patient visits; >90% routine care revenue Dentalcorp is larger than DSO competitors 2-5 combined 70-75% of Canadians see a
Slide 22: Comparison of Valuation and Free Cash Flow Yield vs. Peers
Comparison of Valuation and Free Cash Flow Yield vs. Peers Trading Multiple (Enterprise Value/LTM Adjusted EBITDA)1 Peer Mean (Q2 2025): 15.5x 5.8x discount as of Q2 2025 3 4 Free Cash Flow Yield (LTM Adjusted Free Cash Flow/Market Capitalization)2 5.6% premium as of Q2 2025 Peer Mean (Q2 2025): 3.9
Slide 23: Highly Variable Practice-Level Cost Structure
Highly Variable Practice-Level Cost Structure A Provider compensation includes dentist and hygienist compensation 100% fee for service or hourly wage B Lab fees are pass through and relate to offering of specific services 100% pass through to patient C Employment expenses include practice administra
Slide 24: Long Track Record of Driving Strong Growth
Long Track Record of Driving Strong Growth PRACTICE GROWTH (Number of Practices) PF REVENUE2 ($M) CAGR1: 8.6% 5 1 5 5 CAGR1: 20.1% 542 545 458 9 1,599 1, 1 1,4 1, 9 1,114 Dec 1, 2020 Dec 1, 2021 Dec 1, 2022 Dec 1, 202 Dec 1, 2024 un 0, 2025 Dec 1, 2020 Dec 1, 2021 Dec 1, 2022 Dec 1, 202 Dec 1, 2024
Slide 25: Appendix
Company Overview Investment Highlights Appendix
Slide 26: Senior Leadership
Senior Leadership Graham Rosenberg | Chief Executive Officer & Chairman Nate Tchaplia | President & Chief Financial Officer ▪ Founded Dentalcorp in 2011 ▪ Joined Dentalcorp in 2015 ▪ Serves on the Board of Directors for North York General Hospital ▪ Experienced financial professional having previous
Slide 27: Board of Directors
Board of Directors Graham Rosenberg | Chief Executive Officer & Chairman Jeffrey Rosenthal | Lead Director ▪ Founded Dentalcorp in 2011 ▪ Managing Partner and co-founder of Imperial Capital, a mid-market private ▪ Serves on the Board of Directors for North York General Hospital equity firm Foundatio